During the past decade, AMR Tempe conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AMR Tempe" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Emergent BioSolutions" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Inovio Pharmaceuticals" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AMR Tempe" #1 collaborator was "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "OSTAtistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "AMR Tempe" are "Acute Migraine" (1 trials), "Anthrax" (1 trials), "Botulinum Toxin" (1 trials), "COVID-19 Disease" (1 trials) and "COVID-19 Prevention" (1 trials). Many other conditions were trialed in "AMR Tempe" in a lesser frequency.

Most popular intervention types in "AMR Tempe" are "Drug" (8 trials), "Biological" (7 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ad26.COV2.S" (2 trials), "AV7909" (1 trials), "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials) and "Ad26.ZEBOV" (1 trials). Other intervention names were less common.

The vast majority of trials in "AMR Tempe" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "AMR Tempe". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in AMR Tempe, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AMR Tempe, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".